SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-18-004816
Filing Date
2018-03-23
Accepted
2018-03-23 18:08:21
Documents
2
Period of Report
2018-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1676
2 ex24markel.txt EX-24 3504
  Complete submission text file 0001179110-18-004816.txt   6532
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Markel Stacy (Reporting) CIK: 0001734780 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-29889 | Film No.: 18711277